Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns

United Nations (UN), Department of Economic and Social Affairs, Population Division. World population ageing 2019: highlights (ST/ESA/SER.A/430). New York, USA: United Nations; 2019. Rea, 2018, Age and age-related diseases: role of inflammation triggers and cytokines, Front Immunol, 9, 586, 10.3389/fimmu.2018.00586 Diamanti-Kandarakis, 2017, Aging and anti-aging: a combo-endocrinology overview, Eur J Endocrinol, 176, 283, 10.1530/EJE-16-1061 Reisman, 2004, Anti-aging medicine: the legal issues: legal issues associated with the current and future practice of anti-aging medicine, J Gerontol A Biol Sci Med Sci, 59, B674, 10.1093/gerona/59.7.B674 Yamamoto, 2014, Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion, PLoS ONE, 9, e98972, 10.1371/journal.pone.0098972 Bieganowski, 2004, Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans, Cell, 117, 495, 10.1016/S0092-8674(04)00416-7 Marinescu, 2018, Size exclusion chromatography method for purification of nicotinamide mononucleotide (NMN) from bacterial cells, Sci Rep, 8, 1, 10.1038/s41598-018-22806-8 Poddar, 2019, Nicotinamide mononucleotide: exploration of diverse therapeutic applications of a potential molecule, Biomolecules, 9, 34, 10.3390/biom9010034 National Centre for Biotechnology Information (NCBI). PubChem Compound Summary for CID 14180, Nicotinamide mononucleotide. [cited 2020 Sep 22]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Nicotinamide-mononucleotide. Mills, 2016, Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice, Cell Metab, 24, 795, 10.1016/j.cmet.2016.09.013 Virtual Computational Chemistry Laboratory [homepage on the Internet]. ALOGPS 2.1. 2001-2016. [updated 2016 cited 2021 Aug 01]. Aqueous solubility calculation. Available from: http://www.vcclab.org. Hou, 2018, NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency, Proc Natl Acad Sci U S A, 115, E1876, 10.1073/pnas.1718819115 Okabe, 2019, Implications of altered NAD metabolism in metabolic disorders, J Biomed Sci, 26, 34, 10.1186/s12929-019-0527-8 Marinescu, 2018, β-nicotinamide mononucleotide (NMN) production in Escherichia coli, Sci Rep, 8, 1, 10.1038/s41598-018-30792-0 Hong, 2020, Nicotinamide mononucleotide: a promising molecule for therapy of diverse diseases by Targeting NAD+ metabolism, Front Cell Dev Biol, 8, 246, 10.3389/fcell.2020.00246 Mouchiroud, 2013, The NAD+/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling, Cell, 154, 430, 10.1016/j.cell.2013.06.016 Fang, 2017, NAD+ in aging: molecular mechanisms and translational implications, Trends Mol Med, 23, 899, 10.1016/j.molmed.2017.08.001 Camacho-Pereira, 2016, CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism, Cell Metab, 23, 1127, 10.1016/j.cmet.2016.05.006 Hall, 2013, The sirtuin family’s role in aging and age-associated pathologies, J Clin Invest, 123, 973, 10.1172/JCI64094 Cantó, 2015, NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus, Cell Metab, 22, 31, 10.1016/j.cmet.2015.05.023 Imai, 2011, Dissecting systemic control of metabolism and aging in the NAD World: the importance of SIRT1 and NAMPT-mediated NAD biosynthesis, FEBS Lett, 585, 1657, 10.1016/j.febslet.2011.04.060 Yang, 2016, NAD+ metabolism: bioenergetics, signaling and manipulation for therapy, Biochim Biophys Acta Proteins Proteom, 1864, 1787, 10.1016/j.bbapap.2016.06.014 Yoshino, 2011, Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet-and age-induced diabetes in mice, Cell Metab, 14, 528, 10.1016/j.cmet.2011.08.014 Gomes, 2013, Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging, Cell, 155, 1624, 10.1016/j.cell.2013.11.037 Cantó, 2010, Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle, Cell Metab, 11, 213, 10.1016/j.cmet.2010.02.006 Verdin, 2015, NAD+ in aging, metabolism, and neurodegeneration, Science, 350, 1208, 10.1126/science.aac4854 Imai, 2010, A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis, Pharmacol Res, 62, 42, 10.1016/j.phrs.2010.01.006 Lim, 2010, Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1α, Mol Cell, 38, 864, 10.1016/j.molcel.2010.05.023 De Picciotto, 2016, Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice, Aging Cell, 15, 522, 10.1111/acel.12461 Kawamura, 2016, β-Nicotinamide mononucleotide, an anti-aging candidate compound, is retained in the body for longer than nicotinamide in rats, J Nutr Sci Vitaminol, 62, 272, 10.3177/jnsv.62.272 Guan, 2017, Nicotinamide mononucleotide, an NAD+ precursor, rescues age-associated susceptibility to AKI in a sirtuin 1–dependent manner, J Am Soc Nephrol, 28, 2337, 10.1681/ASN.2016040385 Li, 2017, A conserved NAD+ binding pocket that regulates protein-protein interactions during aging, Science, 355, 1312, 10.1126/science.aad8242 Tsubota, 2017, Anti-aging approach for ocular disorders: from dry eye to retinitis pigmentosa and myopia, Nippon Ganka Gakkai Zasshi, 121, 232 Das, 2018, Impairment of an endothelial NAD+-H2S signaling network is a reversible cause of vascular aging, Cell, 173, 74, 10.1016/j.cell.2018.02.008 Johnson, 2018, CA1 NAMPT knockdown recapitulates hippocampal cognitive phenotypes in old mice which nicotinamide mononucleotide improves, npj Aging Mech Dis, 4, 1, 10.1038/s41514-018-0029-z Hosseini, 2019, Nicotinamide mononucleotide and melatonin alleviate aging-induced cognitive impairment via modulation of mitochondrial function and apoptosis in the prefrontal cortex and hippocampus, Neuroscience, 423, 29, 10.1016/j.neuroscience.2019.09.037 Kiss, 2019, Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects, Geroscience, 41, 419, 10.1007/s11357-019-00095-x Song, 2019, Nicotinamide mononucleotide promotes osteogenesis and reduces adipogenesis by regulating mesenchymal stromal cells via the SIRT1 pathway in aged bone marrow, Cell Death Dis, 10, 1, 10.1038/s41419-019-1569-2 Tarantini, 2019, Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice, Redox Boil, 24, 101192, 10.1016/j.redox.2019.101192 Hosseini, 2020, Melatonin and nicotinamide mononucleotide attenuate myocardial ischemia/reperfusion injury via modulation of mitochondrial function and hemodynamic parameters in aged rats, J Cardiovasc Pharmacol Ther, 25, 240, 10.1177/1074248419882002 Kiss, 2020, Nicotinamide mononucleotide (NMN) supplementation promotes neurovascular rejuvenation in aged mice: transcriptional footprint of SIRT1 activation, mitochondrial protection, anti-inflammatory, and anti-apoptotic effects, GeroScience, 42, 527, 10.1007/s11357-020-00165-5 Miao, 2020, Nicotinamide mononucleotide supplementation reverses the declining quality of maternally aged oocytes, Cell Rep, 32, 107987, 10.1016/j.celrep.2020.107987 Bertoldo, 2020, NAD+ repletion rescues female fertility during reproductive aging, Cell Rep, 30, 1670, 10.1016/j.celrep.2020.01.058 Fu R, Zhang Q. Inventors; Hoboomlife Bio-Technology Co Ltd, assignee. Use of β-nicotinamide mononucleotide in preparation of anti-aging drugs or health-care products. United States patent application US 15/310,371; 2017 Sep 21. [cited 2020 Oct 25]. Available from: https://patents.google.com/patent/US20170266213A1/en. Wahl, 2020, Antiaging therapies, cognitive impairment, and dementia, J Gerontol A, 75, 1643, 10.1093/gerona/glz135 Fang, 2019, Mitophagy and NAD+ inhibit Alzheimer disease, Autophagy, 15, 1112, 10.1080/15548627.2019.1596497 Long, 2015, Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer’s disease-relevant murine model, BMC Neurol, 15, 1, 10.1186/s12883-015-0272-x Wang, 2016, Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death, Brain Res, 1643, 1, 10.1016/j.brainres.2016.04.060 Yao, 2017, Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease, Neurosci Lett, 647, 133, 10.1016/j.neulet.2017.03.027 Klimova, 2019, Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3-dependent mechanism in male mice, J Neurosci Res, 97, 975, 10.1002/jnr.24397 Lu, 2014, Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson's disease, Exp Ther Med, 8, 943, 10.3892/etm.2014.1842 Fang, 2019, NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome, Nat Commun, 10, 1, 10.1038/s41467-019-13172-8 Okur, 2020, Short-term NAD+ supplementation prevents hearing loss in mouse models of Cockayne syndrome, npj Aging Mech Dis, 6, 1, 10.1038/s41514-019-0040-z Fang, 2016, NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair, Cell Metab, 24, 566, 10.1016/j.cmet.2016.09.004 Tosato, 2007, The aging process and potential interventions to extend life expectancy, Clin Interv Aging, 2, 401 Cardona, 2012, Dangers and dilemmas surrounding the consumption of anti-ageing medicine, 35 Yoshino, 2021, Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women, Science, eabe9985 Brower, 2005, A nutraceutical a day may keep the doctor away: Consumers are turning increasingly to food supplements to improve wellbeing when pharmaceuticals fail, EMBO Rep, 6, 708, 10.1038/sj.embor.7400498 Rajman, 2018, Therapeutic potential of NAD-boosting molecules: the in vivo evidence, Cell Metab, 27, 529, 10.1016/j.cmet.2018.02.011 Mehmel, 2020, Nicotinamide riboside-the current State of research and therapeutic uses, Nutrients, 12, 1616, 10.3390/nu12061616 Braidy, 2019, Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets for age-related degenerative diseases: rationale, biochemistry, pharmacokinetics, and outcomes, Antioxid Redox Signal, 30, 251, 10.1089/ars.2017.7269 Grozio, 2019, Slc12a8 is a nicotinamide mononucleotide transporter, Nature Metab, 1, 47, 10.1038/s42255-018-0009-4 Knip, 2000, Safety of high-dose nicotinamide: a review, Diabetologia, 43, 1337, 10.1007/s001250051536 Hwang, 2020, Possible adverse effects of high-dose nicotinamide: mechanisms and safety assessment, Biomolecules, 10, 687, 10.3390/biom10050687 Assiri, 2019, Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease, Hum Genomics, 13, 1, 10.1186/s40246-019-0251-1 Li, 2013, Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats, Br J Nutr, 110, 2156, 10.1017/S0007114513001815 Harrison, 2019, The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease, J Neurochem, 148, 136, 10.1111/jnc.14599 Rolfe, 2014, A review of nicotinamide: treatment of skin diseases and potential side effects, J Cosmet Dermatol, 13, 324, 10.1111/jocd.12119 Dellinger, 2017, Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study, npj Aging Mech Dis, 3, 1, 10.1038/s41514-017-0016-9 Dollerup, 2018, A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects, Am J Clin Nutr, 108, 343, 10.1093/ajcn/nqy132 Shi, 2019, High dose of dietary nicotinamide riboside induces glucose intolerance and white adipose tissue dysfunction in mice fed a mildly obesogenic diet, Nutrients, 11, 2439, 10.3390/nu11102439 Uddin, 2016, Head-to-head comparison of short-term treatment with the NAD+ precursor nicotinamide mononucleotide (NMN) and 6 weeks of exercise in obese female mice, Front Pharmacol, 7, 258, 10.3389/fphar.2016.00258 Conze, 2019, Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults, Sci Rep, 9, 1, 10.1038/s41598-019-46120-z Cros, 2021, Safety evaluation after acute and sub-chronic oral administration of high purity nicotinamide mononucleotide (NMN-C®) in Sprague-Dawley rats, Food Chem Toxicol, 150, 112060, 10.1016/j.fct.2021.112060 Conze, 2016, Safety assessment of nicotinamide riboside, a form of vitamin B3, Hum Exp Toxicol, 35, 1149, 10.1177/0960327115626254 Tsubota, 2016, K, The first human clinical study for NMN has started in Japan, npj Aging Mech Dis, 2, 16021, 10.1038/npjamd.2016.21 Irie, 2020, Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men, Endocr J, 67, 153, 10.1507/endocrj.EJ19-0313 Di Stefano, 2015, A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration, Cell Death Differ, 22, 731, 10.1038/cdd.2014.164 Poljsak, 2018, Vitamin B3 forms as precursors to NAD+: are they safe?, Trends Food Sci Technol, 79, 198, 10.1016/j.tifs.2018.07.020 Radenkovic, 2020, Clinical evidence for targeting NAD therapeutically, Pharmaceuticals, 13, 247, 10.3390/ph13090247 Mendelsohn, 2019, Interacting NAD+ and cell senescence pathways complicate antiaging therapies, Rejuvenation Res, 22, 261, 10.1089/rej.2019.2218 Yu, 2021, Exercise-induced benefits on glucose handling in a model of diet-induced obesity are reduced by concurrent nicotinamide mononucleotide, Am J Physiol Endocrinol Metab, 321, E176, 10.1152/ajpendo.00446.2020